162 related articles for article (PubMed ID: 1982277)
1. Effect of HIV-1 infection on CD4 cells in a hemophilia cohort.
Green D; Deutsche J; Tang M; Goldsmith J
Haematologica; 1990; 75 Suppl 5():132-41. PubMed ID: 1982277
[No Abstract] [Full Text] [Related]
2. Impact of replacement therapy on the evolution of HIV infection in hemophiliacs.
Berntorp E
Thromb Haemost; 1994 Jun; 71(6):678-83. PubMed ID: 7974331
[No Abstract] [Full Text] [Related]
3. Changes in CD4 count relative to product usage: findings from the transfusion safety study.
Hilgartner MW
Semin Hematol; 1993 Oct; 30(4 Suppl 5):7-9. PubMed ID: 7903481
[No Abstract] [Full Text] [Related]
4. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
Seremetis SV
Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
[No Abstract] [Full Text] [Related]
5. In vitro immunoglobulin synthesis as a CD4+ lymphocyte depletion predictor in HIV-1-infected asymptomatic haemophiliacs.
Cavallin F; Traldi A; Di Gaetano R; Zambello R
AIDS; 1994 Dec; 8(12):1728-9. PubMed ID: 7888124
[No Abstract] [Full Text] [Related]
6. [Virus in hemophilia: current status and future perspectives].
Aguilar C; Félix Lucía J
Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
[No Abstract] [Full Text] [Related]
7. Decreased helper-suppressor cell ratios following treatment with blood products: factor VIII and IX concentrates and fresh frozen plasma.
Ragni MV; Lewis JH; Spero JA; Bontempo FA; Rabin BS
Scand J Haematol Suppl; 1984; 40():371. PubMed ID: 6236552
[No Abstract] [Full Text] [Related]
8. [Hemophilia and HTLV-III infection].
Lechler E
Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442
[TBL] [Abstract][Full Text] [Related]
9. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.
Yoo TW; Donfield S; Lail A; Lynn HS; Daar ES;
J Infect Dis; 2005 Jan; 191(1):4-10. PubMed ID: 15592996
[TBL] [Abstract][Full Text] [Related]
10. AIDS and preventive treatment in hemophilia.
Desforges JF
N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
[No Abstract] [Full Text] [Related]
11. Update: acquired immunodeficiency syndrome (AIDS) in persons with hemophilia.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1984 Oct; 33(42):589-91. PubMed ID: 6434934
[No Abstract] [Full Text] [Related]
12. [Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
Astermark J; Berntorp E; Stigendal L; Johnsson H
Lakartidningen; 1998 Jan; 95(1-2):48-50. PubMed ID: 9458646
[TBL] [Abstract][Full Text] [Related]
13. Modulation of allogeneic cytotoxic activity by factor VIII or IX concentrates.
Soria AG; Bouzas MB; Anselmo A; Ruibal-Ares BH
Haematologica; 1991; 76(1):33-7. PubMed ID: 1829058
[TBL] [Abstract][Full Text] [Related]
14. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor development and successful immune tolerance in an HIV-infected patient with haemophilia A and after immune reconstitution with HAART.
Kruse-Jarres R; Hadi CM; Leissinger CA
Haemophilia; 2007 Nov; 13(6):707-11. PubMed ID: 17973846
[TBL] [Abstract][Full Text] [Related]
16. Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs.
Tóth FD; Kiss J; Szabó B; Füst G; Ujhelyi E; Hollán SR; Váczi L
Acta Virol; 1989 Dec; 33(6):521-6. PubMed ID: 2576594
[TBL] [Abstract][Full Text] [Related]
17. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.
Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D
Genetica; 1995; 95(1-3):25-50. PubMed ID: 7538088
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs.
Sorice F; Ghirardini A; Martino P; Pasqualetti D; Annino L; Micozzi A; Cirelli A; Tamburrini E; Isacchi G; Buttò S
Haematologica; 1989; 74(2):149-54. PubMed ID: 2568323
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
[TBL] [Abstract][Full Text] [Related]
20. Markers as time-dependent covariates in relative risk regression. MAP Workshop (Multi-cohort Analysis Project).
Stat Med; 1993 Nov; 12(22):2087-98. PubMed ID: 7906048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
